See also this year's filing and all EDGAR filings for this company.
PDF Report 0001660334_2026_Verrica_Pharmaceuticals_Inc.pdf
Logs
Graph
Absolute values for 0001660334, Verrica Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 42,539,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 209,000 |
| 3 | remainder_Assets | 4,383,000 |
| 4 | LiabilitiesCurrent | 16,437,000 |
| 5 | LiabilitiesNoncurrent | 242,000 |
| 6 | remainder_Liabilities | 5,709,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 35,220,000 |
| 9 | ResearchAndDevelopmentExpense | 8,855,000 |
| 10 | remainder_Expenses | 3,687,000 |
| 11 | remainder_Revenues | 35,577,000 |
| 12 | remainder_NetIncome | -5,701,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 47,131,000 |
| 1 | Liabilities | 22,388,000 |
| 2 | Expenses | 47,762,000 |
| 3 | Revenues | 35,577,000 |
| 4 | StockholdersEquity | 24,743,000 |
| 5 | NetIncome | -17,886,000 |
| 6 | ComprehensiveNetIncome | -17,886,000 |
| 7 | BaseVar | 79,279,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.04 |
| 9 | EconomicCapitalRatio | 2.33 |
Edgar->Model Mapping
Feature Distribution
Change over Time
